Original paper
Mitigating alemtuzumab-associated autoimmunity in MS
Volume: 7, Issue: 6
Published: Nov 1, 2020
Abstract
Objective
To determine whether the punctuated administration of low-dose rituximab, temporally linked to B-cell hyperrepopulation (defined when the return of CD19+ B cells approximates 40%–50% of baseline levels as measured before alemtuzumab treatment inception), can mitigate alemtuzumab-associated secondary autoimmunity.Methods
In this hypothesis-driven pilot study, 10 patients received low-dose rituximab (50–150...Paper Details
Title
Mitigating alemtuzumab-associated autoimmunity in MS
Published Date
Nov 1, 2020
Volume
7
Issue
6
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History